TWO VALIDATED TARGETS FOR DEEPER REMISSIONS. NOVEL TARGETS TO ADDRESS MAJOR INDICATIONS.

AUTOLOGOUS. MILD CONDITIONING.

RAPID AND NON-INVASIVE PROCEDURE. PATIENT AND CLINICIAN FRIENDLY WORKFLOW.

SIMPLICITY BY DESIGN.
DIGITALLY DRIVEN.